A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumorsGerhardt Attard, Maja J. De Jonge, Gerhard Zugmaier et al.|Journal of Clinical Oncology|2005Cited by 8